Alberto Gabizon

This inventor holds 15 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Alza Corporation, Lipomedix Pharmaceuticals Ltd.. Active years: 1989-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alberto Gabizon. Retrieved from https://idiyas.com/inventor/alberto-gabizon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 2)

% Patents Active = 93.3

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 542(Granted Patents)

Location History:

San Francisco, CA (US) (1989 - 1991)
Jerusalem, IL (2002 - 2020)

Company Filing History:

5 out of 915

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

Lipomedix Pharmaceuticals Ltd.

patents

4. 3 out of 9

Shaare Zedek Scientific Ltd

patents

5. 2 out of 5

Hadassah Medical Organization

patents

6. 1 out of 1

Hadasit Medical Research, Inc.

patent

7. 1 out of 196

King's College London

patents

8. 1 out of 673

Linear Technology Corporation

patents

9. 1 out of 1

Sharre Zedek Scientific Ltd.

patent

10. 1 out of 1,327

The University of North Carolina at Chapel Hill

patents

11. 1 out of 1

Yissum Research and Development Company Et Al.

patent

12. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2024

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12171746 - Liposome composition comprising liposomal prodrug of mitomycin c and method of manufacture (2024-12-24),

2. 10617672 - Liposome composition co-encapsulating doxorubicin and a prodrug of mitomycin C (2020-04-14),

3. 10085940 - Liposomes co-encapsulating a bisphosphonate and an amphipathic agent (2018-10-02),

4. 10080807 - Combination chemotherapy comprising a liposomal prodrug of mitomycin C (2018-09-25),

5. 9937261 - Combination therapy comprising a liposomal prodrug of mitomycin C and radiotherapy (2018-04-10),

6. 8932627 - Liposomal compositions of glucocorticoid and glucocorticoid derivatives (2015-01-13),

7. 7303760 - Method for treating multi-drug resistant tumors (2007-12-04),

8. 7276248 - Conjugate having a cleavable linkage for use in a liposome (2007-10-02),

9. 6984396 - Conjugate having a cleavable linkage for use in a liposome (2006-01-10),

10. 6787132 - Combined chemo-immunotherapy with liposomal drugs and cytokines (2004-09-07),

11. 6365179 - Conjugate having a cleavable linkage for use in a liposome (2002-04-02),

12. 5043166 - Liposome/anthraquinone drug composition and method (1991-08-27),

13. 4920016 - Liposomes with enhanced circulation time (1990-04-24),

14. 4898735 - Liposome/doxorubicin composition and method (1990-02-06),

15. 4797285 - Lipsome/anthraquinone drug composition and method (1989-01-10),

Title: Alberto Gabizon - Innovator from Jerusalem, IL

Introduction: Alberto Gabizon is a renowned inventor hailing from Jerusalem, Israel, known for his groundbreaking contributions to the field of pharmaceuticals and medical research.

Latest Patents: Alberto Gabizon holds several patents related to innovative drug delivery systems and cancer treatment methods, showcasing his commitment to advancing medical science.

Career Highlights: With a distinguished career spanning over three decades, Gabizon has worked tirelessly to develop novel therapies for cancer patients, earning him recognition as a pioneer in the pharmaceutical industry.

Collaborations: Throughout his career, Alberto Gabizon has collaborated with leading researchers, medical professionals, and pharmaceutical companies worldwide to bring his innovative ideas to life and make a positive impact on patient care.

Conclusion: In conclusion, Alberto Gabizon's passion for innovation and his dedication to improving healthcare have solidified his reputation as a visionary inventor in the field of medicine.

Profile summary based on public USPTO records.